STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
88
13F, latest reported quarter
Conversions, 180 days
13
Codes C/M, not in net · $1.7M priced
What the filings say about DGICA
Insiders, 180 days
+$5.8M net bought
1 buyer · 9 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$943.6K
4 notices
Donegal insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, DONEGAL GROUP INC insiders bought a net $5.8M of stock across 481 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on May 12, 2025.
The trade is 173.0% of the 13,870 shares held after it.
4 other insiders sold within 30 days.
88 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & Chief Exec Officer BURKE KEVIN GERARD sold about $461.4K of DGICA on Sep 11, 2026; 4 other insiders sold within 30 days and 88 funds added in the latest 13F quarter.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on May 12, 2025.
The trade is 77.3% of the 27,176 shares held after it.
4 other insiders sold within 30 days.
88 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP & Chief Financial Officer MILLER JEFFREY DEAN sold about $403.7K of DGICA on Sep 11, 2026; 4 other insiders sold within 30 days and 88 funds added in the latest 13F quarter.
307 earlier Form 4 trades (code P or S) here by this insider (307 buys), the last on Sep 10, 2026.
+12.9% median (+11.8% mean) 90-day return after 11 previous buys.
The trade is 0.3% of the 14,387,128 shares held after it.
No other insider bought within 30 days.
88 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider DONEGAL MUTUAL INSURANCE CO bought about $865.2K of DGICA on Sep 11, 2026, the largest insider purchase at the company since 2025; 88 funds added in the latest 13F quarter.
Nobody has filed for crossing 5%. That is a fact, not missing data.
DGICA planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
HUBER BARRY CRAIG
Filed 2026-09-03
$87.8K
BIXENMAN DENNIS JOSEPH
Filed 2026-08-05
$216.6K
DEAS NOLAND RONE JR
Filed 2026-08-04
$463.2K
KING DAVID CHARLES
Filed 2026-08-04
$175.9K
DGICA mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Royce Capital Fund - Small-Cap Portfolio
$2.5M position · as of 2026-06-30
1.3%
Royce Small-Cap Value Fund
$1.5M position · as of 2026-06-30
1.3%
ProShares Russell 2000 Dividend Growers ETF
$6.0M position · as of 2026-05-31
0.9%
Victory Integrity Discovery Fund
$621.4K position · as of 2026-06-30
0.7%
Hartford Multifactor Small Cap ETF
$293.7K position · as of 2026-07-31
0.5%
First Trust Dow Jones Select MicroCap Index Fund
$1.1M position · as of 2026-06-30
0.4%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$914.4K
$898.0K
$579.3K
+13%
+4%
2022
$1.2M
$1.3M
$751.9K
+9%
+2%
2021
$1.0M
$1.0M
$677.1K
+5%
+6%
2020
$1.3M
$1.3M
$847.3K
-1%
-10%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $5.8M bought by insiders over 180 days, 88 funds added last quarter, $943.6K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$963.2M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM DGICA
FY Dec 2025
$978.4M
FY Dec 2024
$989.6M
FY Dec 2023
$927.3M
FY Dec 2022
$848.2M
FY Dec 2021
$816.5M
Jun 2026
$241.1M
Mar 2026
$236.0M
Dec 2025
$240.1M
Sep 2025
$245.9M
Jun 2025
$247.1M
Mar 2025
$245.2M
Dec 2024
$250.0M
Sep 2024
$251.7M
At each fiscal year end
Single quarter
Net margin, TTM
+7.4%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM DGICA
FY Dec 2025
+8.1%
FY Dec 2024
+5.1%
FY Dec 2023
+0.5%
FY Dec 2022
-0.2%
FY Dec 2021
+3.1%
Jun 2026
+9.3%
Mar 2026
+4.9%
Dec 2025
+7.2%
Sep 2025
+8.2%
Jun 2025
+6.8%
Mar 2025
+10.3%
Dec 2024
+9.6%
Sep 2024
+6.7%
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM DGICA
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity DGICA
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt DGICA
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+11.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity DGICA
FY Dec 2025
+13.4%
FY Dec 2024
+9.9%
FY Dec 2023
+0.9%
FY Dec 2022
-0.4%
FY Dec 2021
+4.8%
Jun 2026
+11.2%
Mar 2026
+10.6%
Dec 2025
+13.4%
Sep 2025
+15.1%
Jun 2025
+15.2%
Mar 2025
+13.1%
Dec 2024
+9.9%
Sep 2024
+5.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets DGICA
FY Dec 2025
+3.4%
FY Dec 2024
+2.2%
FY Dec 2023
+0.2%
FY Dec 2022
-0.1%
FY Dec 2021
+1.1%
Jun 2026
+2.9%
Mar 2026
+2.7%
Dec 2025
+3.4%
Sep 2025
+3.6%
Jun 2025
+3.5%
Mar 2025
+3.0%
Dec 2024
+2.2%
Sep 2024
+1.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital DGICA
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed DGICA
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing DGICA
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value DGICA
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield DGICA
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing DGICA
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
DGICA ranks highest on insider conviction (81st percentile) and risk and compliance (44th), and lowest on growth (16th), among Insurance peers.
Profitability
41
Inputs
Return on equity+11.2% · 36 pct, sector of 116
Return on assets+2.9% · 46 pct, sector of 122
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Growth
16
Inputs
Revenue growth, YoY-1.2% · 16 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
81
Inputs
Net Form 4 buying (codes P and S), 180d$5.8M · 100 pct, sector of 100
Insider buyers, 180d1 · 62 pct, sector of 101
Institutional and government
34
Inputs
Funds adding, latest quarter88 · 34 pct, sector of 108
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
44
Inputs
Short interest, % of float+4.5% · 39 pct, sector of 138
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+10.1% · 50 pct, sector of 110
2 not measured: Financial health, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
DGICA filings, in plain words
Are Donegal insiders buying or selling DGICA?
In the 180 days to 2026-10-27, Donegal insiders were net buyers, a net $5.8M: $8.2M of purchases and $2.4M of sales reported on Form 4, by 1 buyer and 9 sellers.
Are there planned insider sales of DGICA?
Yes. 4 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $943.6K of stock; the latest, by HUBER BARRY CRAIG, was filed 2026-09-03.
Read the full summary
In the 180 days to 2026-10-27, Donegal insiders were net buyers of DGICA, a net $5.8M across purchases and sales reported on Form 4 by 1 buyer and 9 sellers. Most of that figure, $8.2M, came from a holder of 10% or more rather than an officer or director. None of the 9 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 4 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $943.6K of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.